CMFRI Director Dr A Gopalakrishnan said there was a growing demand for new bioactive compounds of marine natural origin in pharmaceutical fields.
He said the institute has already developed and commercialised various nutraceutical products for various diseases such as diabetes, arthritis, cholesterol and obesity.
"In addition, several products from marine organisms as promising therapeutic agents against diseases such as thyroid are in pipeline to be out licensed soon," Gopalakrishnan said in a release here.
Organised by the Marine Biotechnology division of CMFRI, the Winter School on 'recent advances in bioactive compounds from marine organisms' will be attended by 25 researchers and officials from various institutes under the Indian Council of Agricultural Research (ICAR) and the universities from across the country.
"Training will be provided to the budding researchers on various research aspects for developing medicines and other nutraceutical products from sea that include isolation and characterisation of natural products of pharmaceutical importance from marine organisms such as seaweeds, molluscs, sponges, coelenterates, etc," the release said.
Renowned scientists and experts in the area of marine natural product chemistry from across the globe will lead the technical training sessions at the Winter School.
CMFRI is the pioneering marine research institute to work in the frontier area of marine bio-prospecting molecule discovery, marine food product technology and development of high-value nutraceutical products such as dietary and health management supplements.
CMFRI's training programme would help the participants formulate strategies further research in the area, paving the way for an upsurge of research on marine bio-prospecting in the respective laboratories and various institutes of the participants, Gopalakrishnan said.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
